Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▼ |
|---|---|---|---|
| 6UYE | A0A1C4HDV6 | EBOV GPdMuc Makona bound to rEBOV-548 Fab | SGP, Virion spike glycoprotein, Antibody rEBOV-548 Fab, heavy chain, Antibody rEBOV-548 Fab, light chain |
| 6UYE | 6UYE | EBOV GPdMuc Makona bound to rEBOV-548 Fab | SGP, Virion spike glycoprotein, Antibody rEBOV-548 Fab, heavy chain, Antibody rEBOV-548 Fab, light chain |
| 5G47 | R4V2Q5 | Structure of Gc glycoprotein from severe fever with thrombocytopenia syndrome virus in the trimeric postfusion conformation | SFTSV GC |
| 4HHQ | 4HHQ | Serum paraoxonase-1 by directed evolution with the H115Q and H134Q mutations | SERUM PARAOXONASE BY DIRECTED EVOLUTION (E.C.3.1.1.2) |
| 4HHO | 4HHO | Serum paraoxonase-1 by directed evolution with the H115W mutation | SERUM PARAOXONASE BY DIRECTED EVOLUTION |
| 1BCS | P08819 | COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, CHYMOSTATIN, AND ARGININE AT 100 DEGREES KELVIN | SERINE CARBOXYPEPTIDASE II, ARGININE, [[PHENYLALANINE-CARBONYL-AMINO-2-(2-AMINO-1,4,5,6-TETRAHYDRO-PYRIMIDIN-4-YL)-1-ACETALDEHYDYL]-2-ISOBUTYL-GLYCYL]PHENYLALANINE |
| 1BCS | 1BCS | COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, CHYMOSTATIN, AND ARGININE AT 100 DEGREES KELVIN | SERINE CARBOXYPEPTIDASE II, ARGININE, [[PHENYLALANINE-CARBONYL-AMINO-2-(2-AMINO-1,4,5,6-TETRAHYDRO-PYRIMIDIN-4-YL)-1-ACETALDEHYDYL]-2-ISOBUTYL-GLYCYL]PHENYLALANINE |
| 1WHT | P08819 | STRUCTURE OF THE COMPLEX OF L-BENZYLSUCCINATE WITH WHEAT SERINE CARBOXYPEPTIDASE II AT 2.0 ANGSTROMS RESOLUTION | SERINE CARBOXYPEPTIDASE II (E.C.3.4.16.1) COMPLEXED WITH L-BENZYLSUCCINATE |
| 1WHS | P08819 | STRUCTURE OF THE COMPLEX OF L-BENZYLSUCCINATE WITH WHEAT SERINE CARBOXYPEPTIDASE II AT 2.0 ANGSTROMS RESOLUTION | SERINE CARBOXYPEPTIDASE II (E.C.3.4.16.1) (NATIVE FORM) |
| 3SC2 | P08819 | REFINED ATOMIC MODEL OF WHEAT SERINE CARBOXYPEPTIDASE II AT 2.2-ANGSTROMS RESOLUTION | SERINE CARBOXYPEPTIDASE II (E.C.3.4.16.1) (CPDW-II) |
| 1YSC | P00729 | 2.8 ANGSTROMS STRUCTURE OF YEAST SERINE CARBOXYPEPTIDASE | SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEINASE C) (E.C.3.4.16.5) |
| 1CPY | P00729 | SITE-DIRECTED MUTAGENESIS ON (SERINE) CARBOXYPEPTIDASE Y FROM YEAST. THE SIGNIFICANCE OF THR 60 AND MET 398 IN HYDROLYSIS AND AMINOLYSIS REACTIONS | SERINE CARBOXYPEPTIDASE |
| 7LQV | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 4-8 Fab |
| 7LQV | 7LQV | Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 4-8 Fab |
| 7LQW | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 2-17 Fab |
| 7LQW | 7LQW | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 2-17 Fab |
| 7KKL | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody mNb6 |
| 7KKL | 7KKL | SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody mNb6 |
| 7KKK | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody Nb6 |
| 7KKK | 7KKK | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody Nb6 |
| 6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 7JW0 | P0DTC2 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S304 Fab light chain, S304 Fab heavy chain |
| 7JW0 | 7JW0 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S304 Fab light chain, S304 Fab heavy chain |
| 7K43 | P0DTC2 | SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2M11 Fab fragment (heavy chain), S2M11 Fab fragment (light chain) |
| 7K43 | 7K43 | SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2M11 Fab fragment (heavy chain), S2M11 Fab fragment (light chain) |
| 7JV6 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain |
| 7JV6 | 7JV6 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain |
| 7JVC | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2A4 Fab heavy chain, S2A4 Fab light chain |
| 7JVC | 7JVC | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2A4 Fab heavy chain, S2A4 Fab light chain |
| 7KSG | P0DTC2 | SARS-CoV-2 spike in complex with nanobodies E | SARS-CoV-2 spike glycoprotein, Nanobody against SARS-CoV-2 glycoprotein |
| 7KSG | 7KSG | SARS-CoV-2 spike in complex with nanobodies E | SARS-CoV-2 spike glycoprotein, Nanobody against SARS-CoV-2 glycoprotein |
| 6XEY | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6XEY | 6XEY | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6XEY | A0A5C2GJG2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 7L2D | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain |
| 7L2D | 7L2D | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain |
| 6X6P | P0DTC2 | Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis | SARS-CoV-2 spike glycoprotein |
| 6X79 | P0DTC2 | Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation | SARS-CoV-2 spike glycoprotein |
| 7CAB | P0DTC2 | Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody | SARS-CoV-2 Spike glycoprotein |
| 6Z97 | P10104 | Structure of the prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 RBD, Heavy Chain, Light chain |
| 6Z97 | P0DTC2 | Structure of the prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 RBD, Heavy Chain, Light chain |
| 1FQ4 | P07267 | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP-108,420 AND YEAST ASPARTIC PROTEINASE A | SACCHAROPEPSIN (E.C.3.4.23.25) |
| 1FQ5 | P07267 | X-ray structure of a cyclic statine inhibitor PD-129,541 bound to yeast proteinase A | SACCHAROPEPSIN (E.C.3.4.23.25) |
